{"id":"W4389229400","doi":"10.1182/blood-2023-189096","title":"Safety, Tolerability, and Pharmacokinetics of Nirsevimab for the Prevention of RSV Disease in Immunocompromised Children Aged ≤24 Months: Music, an Open Label, Phase 2 Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Respiratory viral infections research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Internal medicine; Palivizumab; Lower respiratory tract infection; Respiratory tract infections; Pediatrics; Immunology; Respiratory system","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002025401,0.001095008,0.001710281,0.0004132988,0.0003313785,0.0009889139,0.0007845897,0.001142762,0.003319849],"category_scores_gemma":[0.001664218,0.0004074719,0.001288418,0.00032522,0.0008228477,0.0009764192,0.0003453879,0.002017444,0.0005871827],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006928784,"about_ca_system_score_gemma":0.001010009,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003677538,"about_ca_topic_score_gemma":0.001101328,"domain_scores_codex":[0.9992924,0.0003427323,0.00005576887,0.0001022254,0.0001003448,0.0001066269],"domain_scores_gemma":[0.9991967,0.0001596651,0.0002445412,0.00006583396,0.00005678539,0.0002764569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8283901,0.0225144,0.01419093,0.00125749,0.001593449,0.0002803121,0.0002723898,0.001586909,0.02450897,0.0002135844,0.003426252,0.1017652],"study_design_scores_gemma":[0.5354933,0.4147168,0.03647775,0.0001057536,0.001227737,0.0005939515,0.00007878441,0.001296925,0.004192001,0.0002942767,0.005467627,0.0000551363],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894392,0.004389793,0.0002699835,0.000214078,0.00007121851,0.002066187,0.00173805,0.00007593313,0.001735687],"genre_scores_gemma":[0.988213,0.002724597,0.001308261,0.0006083681,0.0002806297,0.002823964,0.002347857,0.00002554369,0.001667775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003319849,"threshold_uncertainty_score":0.01110601,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1113871959486343,"score_gpt":0.4350142645533265,"score_spread":0.3236270686046922,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}